ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| ADC TELECOMM (NYSE: ADCT) | Delayed: 1.54 +0.01 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.53 | 52 Week High | $12.76 | |||
| Open | $1.58 | 52 Week Low | $5.18 | |||
| Day High | $1.68 | P/E | 1.97 | |||
| Day Low | $1.50 | EPS | $0.78 | |||
| Volume | 1,071,496 | |||||
